Catalyst Wire Dossier Catalyst Wire Dossier

Flavocoxid 500 mg

flavocoxid · Primus Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flavocoxid 500 mg, covering 2022-11-01 to 2022-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee [NA]

See pricing